CGEN and AZN Related Headlines

Go Back

Aug 26, 2026 07:00AM Daiichi Sankyo and AstraZeneca start phase 3 urothelial cancer trial

Aug 26, 2026 07:00AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

Oct 17, 2025 10:00AM DATROWAY plus rilvegostomig shows tumor responses in urothelial cancer trial

Oct 17, 2025 10:00AM DATROWAY® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial

CGEN and AZN Related Press Releases

Go Back

Aug 26, 2026 07:00AM TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

Oct 17, 2025 10:00AM DATROWAY® Plus Rilvegostomig Showed Promising Tumor Responses in Patients with Metastatic Urothelial Cancer in TROPION-PanTumor03 Phase 2 Trial

CGEN and AZN Related SEC Filings

Go Back